FindTrial
Sign In

Evaluation of Extracorporal Shockwave Therapy (ESWT) in Achilles tendinopathy using Shear Wave Elastography (SWE) and Ultrasound Tissue Characterisation (UTC): a single-blinded, placebo-controlled randomised clinical trial.

Evaluation of Extracorporal Shockwave Therapy (ESWT) in Achilles tendinopathy using Shear Wave Elastography (SWE) and Ultrasound Tissue Characterisation (UTC): a single-blinded, placebo-controlled randomised clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00014594
Enrollment
60
Registered
2018-06-14
Start date
2018-07-02
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M76.6

Interventions

Group 1: group A: physiotherapy (eccentric exercises
isometric exercises
static stretching) + placebo ESWT (beginning, after 2 weeks, after 4 weeks, after 6 weeks) Group 2: group B: physiotherapy (eccentric exercises
static stretching) + linear focused ESWT (beginning, after 2 weeks, after 4 weeks, after 6 weeks) Group 3: group C: physiotherapy (eccentric exercises
static stretching) + point focused ESWT (beginning, after 2 weeks, after 4 weeks, after 6 weeks)

Sponsors

Universitätsklinikum AachenKlinik für Orthopädie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Achilles tendinopathy with symptoms at least for 3 months

Exclusion criteria

Exclusion criteria: pregnancy, underage, under- weight and overweight (BMI>35, BMI <17), injections with cortison or other substances in the last 6 months or planned injections in the followin 6 months, operations on the Achilles tendon. Explicit contraindications for usage of ESWT are malignt tumors in the area of pain as well as an bacterial oseteomyelitis.

Design outcomes

Primary

MeasureTime frame
6 month: pain scores (VISA-A Score, AOFAS Score, Likert Scale, Roles and Maudesly Score) // B-Mode (tendon thickness, hypoechogenity, calcification, morphology (fusiform etc.), echo pattern) // PowerDoppler (Öhberg Score) // ShearWaveElastograhy (SWE) (mean SWE values (ins. + mid-portion) // Ultrasound Tissue Characterisation (UTC) (percentage distribution of echo types)—

Secondary

MeasureTime frame
6 weeks: pain scores (VISA-A Score, AOFAS Score, Likert Scale, Roles and Maudesly Score) // B-Mode (tendon thickness, hypoechogenity, calcification, morphology (fusiform etc.), echo pattern) // PowerDoppler (Öhberg Score) // ShearWaveElastograhy (SWE) (mean SWE values (ins. + mid-portion) // Ultrasound Tissue Characterisation (UTC) (percentage distribution of echo types)—

Countries

Germany

Contacts

Public ContactMatthias Gatz

Universitätsklinikum AachenKlinik für Orthopädie

sehnenprobleme@ukaachen.de0049/241-80-89589

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026